Neurocrine Bio. (NBIX) PT Raised to $120 at SVB Leerink
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $161.62 --0%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
SVB Leerink analyst Marc Goodman raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $120.00 (from $105.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Outdoor Holding (POWW) PT Raised to $2.75 at Roth/MKM, reiterates Top Pick
- Norwegian Cruise (NCLH) PT Raised to $24 at TD Cowen
- Southwest (LUV) PT Raised to $61 at UBS Ahead of Q2 Print
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
